Synoste Overview

  • Founded
  • 2012
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 15
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $25.3M
Latest Deal Amount

Synoste General Information

Description

Developer of novel patient-friendly medical solutions designed for the treatment of skeletal deformities. The company offers a 3rd generation limb lengthening system that utilizes smart materials and introduces a less painful and precisely controllable treatment device to perform limb-lengthening procedures with lower complication rates, thereby enabling patients to have a faster recovery to normal life.

Contact Information

Website
www.synoste.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Technology Systems
Parent Company
Primary Office
  • Metsänneidonkuja 6
  • 02130 Espoo
  • Finland
+358 045 0000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Synoste Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Merger/Acquisition 01-Jan-2020 $25.3M 000.00 000.00 Completed Generating Revenue
9. Debt - General 00.000 000.00 Completed Clinical Trials - General
8. Early Stage VC (Series B) 18-Oct-2018 00.000 000.00 000.00 Completed Clinical Trials - General
7. Early Stage VC (Series A2) 22-Dec-2015 00.000 00.000 00.00 Completed Generating Revenue
6. Early Stage VC (Series A1) 24-Apr-2015 00.000 00.000 00.000 Completed Generating Revenue
5. Accelerator/Incubator 00.00 Completed Generating Revenue
4. Grant 00.000 00.00 Completed Generating Revenue
3. Seed Round 14-Nov-2013 00.000 00.00 00.000 Completed Generating Revenue
2. Accelerator/Incubator $269K Completed Generating Revenue
1. Capitalization 19-Feb-2013 $269K $269K Completed Generating Revenue
To view Synoste’s complete valuation and funding history, request access »

Synoste Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of novel patient-friendly medical solutions designed for the treatment of skeletal deformities. The company of
Therapeutic Devices
Espoo, Finland
15 As of 2019
000.00
00.00 0000-00-00
000000&0 000.00

00000000

r adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad min
00000000000 0000000
Minneapolis, MN
00 As of 0000
00000
0000 0000-00-00
00000000000 00000

00000000

quip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum
00000000 0000000
Plymouth, MN
00 As of 0000
00000
0000 0000-00-00
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Synoste Competitors (21)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Relievant Medsystems Venture Capital-Backed Minneapolis, MN 00 00000 00000000000 00000
00000000000 Venture Capital-Backed Plymouth, MN 00 00000 00000000000 00000
00000000 000000000 Venture Capital-Backed Holland, MI 0 000.00 000000000 000.00
00000 0000 Venture Capital-Backed Shelton, CT 000 00000 000000000 - 00000
000000000 Corporation Minneapolis, MN 00000 00000000
You’re viewing 5 of 21 competitors. Get the full list »

Synoste Executive Team (4)

Name Title Board Seat Contact Info
Harri Hallila Co-Founder, Managing Director & Board Member
Antti Ritvanen Co-Founder, Director, Product Development & Board Member
Juha Haaja Co-Founder & Director, Technology
You’re viewing 3 of 4 executive team members. Get the full list »

Synoste Board Members (6)

Name Representing Role Since
Antti Ritvanen Synoste Co-Founder, Director, Product Development & Board Member 000 0000
Harri Hallila Synoste Co-Founder, Managing Director & Board Member 000 0000
You’re viewing 2 of 6 board members. Get the full list »

Synoste Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Synoste Former Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Aalto Start-Up Center Accelerator/Incubator 000 0000 000000 0
EIT Digital Accelerator/Incubator 000 0000 000000 0
Eurostars Government Minority 000 0000 000000 0
Evonik Venture Capital Corporate Venture Capital Minority 000 0000 000000 0
High-Tech Gründerfonds Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »